Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

What Is Ataxia-Telangiectasia? Mutation, Symptoms, and Treatment

What Is Ataxia-Telangiectasia? Mutation, Symptoms, and Treatment

What Is Ataxia-Telangiectasia?

Ataxia-telangiectasia (AT) is characterized by progressive neurological problems that cause difficulty walking and an increased risk of developing various types of cancer. It is an inherited condition. It is considered a disease in the inherited cancer syndrome category.

Ataxia-telangiectasia symptoms usually develop during childhood. Soon after learning to walk, children with ataxia-telangiectasia may stagger or lose their balance while walking; this is called ataxia. Most people with ataxia-telangiectasia may eventually need to use a wheelchair.

People with ataxia-telangiectasia have normal intelligence, but over time they develop speech impairment and have difficulty writing and performing other tasks. Red spots originating from capillaries, called telangiectasia, may develop on the skin and in the eyes as the person gets older. People with ataxia-telangiectasia also have weakened immune systems and are prone to infections. In addition, they are particularly sensitive to ionizing radiation such as X-rays and have an increased risk of cancer.

what is ataxia telangiectasia what are its symptoms infographic image

What Causes Ataxia-Telangiectasia?

Ataxia-telangiectasia (AT) is a genetic condition. This means that the risk of AT is passed down from generation to generation in a family.

The gene associated with AT is ATM, meaning ataxia telangiectasia mutated. Mutations (changes) in the ATM gene cause AT.

The ATM gene is located on chromosome 11 and helps repair damaged DNA and control cell growth.

How Is Ataxia-Telangiectasia Inherited?

Normally, each cell has 2 copies of every gene: 1 from the mother and 1 from the father. AT follows an autosomal recessive inheritance pattern. In autosomal recessive inheritance, a mutation must be present in both copies of a gene for a person to be affected by the disease. This means both parents must pass on a gene mutation for a child to be affected. A person with only 1 copy of the gene mutation is called a carrier. When both parents carry the recessive gene mutation, a child has a 25% chance of inheriting 2 mutations and being affected by AT. First-degree relatives of a person with AT, such as parents, brothers, sisters, and children, have a 50% chance of inheriting the single gene mutation and being carriers.

Options are available for people who carry an ATM gene mutation and want to have children. Preimplantation genetic diagnosis (PGD) is a medical procedure performed together with in vitro fertilization (IVF) that may allow a person to have a child without passing on the ATM gene. A woman's eggs are removed and fertilized in a laboratory. When the embryos reach a certain size (approximately 8 cells), 1 cell is removed and tested for the inherited condition in question. Parents may then choose to transfer embryos without the mutation to the woman's uterus. PGD has been used for more than twenty years to prevent various inherited cancer predisposition syndromes. However, it is a complex procedure, and financial, physical, and emotional factors should be considered before starting PGD.

How Common Is Ataxia-Telangiectasia?

AT is rare. It is estimated to affect one in 40 thousand to one in 100 thousand people. A person has approximately a 1% chance of carrying a single ATM gene mutation.

 How Is Ataxia-Telangiectasia Diagnosed?

AT is suspected when a child shows signs of ataxia, such as unsteady walking. The ATM gene can be identified through testing, and genetic mutations can be detected in approximately 90% of people with AT. The following tests may help determine whether a person has AT or another type of ataxia:

  • Immunoblotting (ATM protein testing):  This is the best test for diagnosing AT. Almost all individuals with AT have very little or none of the protein made by the ATM gene.
  • Radiosensitivity assay: Because people with AT have increased sensitivity to radiation, removing some cells and treating the sample with radiation therapy may help establish a diagnosis. Results from this test may take up to 3 months.
  • ATM kinase activity: This test looks at the activity level of the protein made by the ATM gene. Very little or no activity means there is probably a mutation in the ATM gene.

What Is the Estimated Cancer Risk Associated With AT?

People with AT also have an approximately 40% risk of developing cancer. The most common cancers in people with AT are leukemia and lymphoma. These two cancers may occur in childhood and account for 85% of all cancers in people with AT. As people with AT live longer, an increased risk of other cancers is seen, including breast cancer, ovarian cancer, stomach cancer, melanoma, and sarcoma.

What Are the Cancer Risks for Carriers of an AT Gene Mutation?

Carriers, meaning people with an ATM gene mutation, also have an increased risk of breast cancer. A carrier may also be called a heterozygote. Some studies have shown a 5 to 9 times higher lifetime breast cancer risk for women who are carriers, while other studies have shown approximately a 2-fold higher lifetime risk than in the general population. It is not yet known whether male ATM carriers have an increased breast cancer risk. Some data suggest that men and women carrying an ATM mutation may have a higher risk of colon and / or stomach cancer, but this is not completely clear at present. Clinical practice guidelines currently recommend more breast and colon cancer screening for ATM mutation carriers than for the general population. Pancreatic cancer risk may also be increased among ATM mutation carriers.

Additional research is needed to clarify cancer risk and other conditions in ATM genetic mutation carriers. Studies also suggest that carriers may have an increased risk of heart disease.

As inherited cancer testing expands to include multigene panels, the classic definition of syndromes such as AT may change. Some people may have mutations in their ATM genes without meeting any of the AT criteria listed above. It is unknown whether these people have the same cancer risks.

What Are the Screening Options for AT?

Children and adults with AT should see their doctors regularly and be monitored for signs of cancer. People with AT who frequently develop infections are advised to have their immune status checked regularly.

Cancer screening guidelines for ATM gene mutation carriers are evolving. Given the growing evidence of a moderate to high increase in breast cancer risk among women with an ATM gene mutation, the US National Comprehensive Cancer Network (US-NCCN) currently recommends breast magnetic resonance imaging (MRI) in addition to annual mammography for these women, and more frequent colonoscopy screening for both male and female ATM gene mutation carriers (every 3-5 years compared with every 10 years for the general population).

Screening options may change over time as new technologies develop and more is learned about AT. It is important to discuss appropriate screening tests with your healthcare team.

Questions to Ask Your Doctor

If you have concerns about your cancer risk, talk with your doctor. Bringing someone close to you to take notes at appointments may help. You may ask your healthcare team the following questions:

  • What is my risk of developing cancer?
  • What is my risk of developing other types of cancer?
  • What can I do to reduce my cancer risk?
  • What are my options for cancer screening?

If you have concerns about your family history and think your family may have AT, you may ask the following questions:

  • Does my family history increase my risk of developing cancer?
  • Could my family have AT?
  • Would you refer me to a genetic counselor or another genetics specialist?
  • Should I consider genetic testing ?

Sources

Ataxia-Telangiectasia. Approved by the Cancer.Net Editorial Board, 01/2020. https://www.cancer.net/cancer-types/ataxia-telangiectasia

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

What Is Ataxia-Telangiectasia? Mutation, Symptoms, and Treatment

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy